Cusack Thomas bought HRTX
November 8, 2025 · Form 4 insider transaction
Cusack Thomas bought 37,879 shares of Heron Therapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
37,879
Price
N/A
Total value
N/A
InsiderCusack Thomas
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateNovember 8, 2025
Filing dateNovember 12, 2025
Shares owned after37,879
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant.; Each restricted stock unit represents a contingent right to receive one share of common stock.